Nasal CDMO Growth Renaissance Lakewood specializes as a CDMO with over 20 years of expertise in nasal sprays and sterile injectables, presenting sales opportunities with clients seeking development through commercial launch support in these dosage forms.

Expanding Capacity Recent facility expansions and new packaging lines indicate increased manufacturing capacity and readiness to scale for growing global demand, offering a compelling case to potential partners needing reliable scale-up and supply security.

Allied Partnerships Active and signaled partnerships with ARS and Tiziana Life Sciences demonstrate a track record of collaboration across development, clinical, and commercial phases, highlighting opportunities for prospective biotech clients seeking integrated CDMO support.

Broad Capabilities Comprehensive services from aseptic fill-finish to nasal spray formulation, analytical testing, and spray characterization position Renaissance as a one-stop shop for end-to-end development, appealing to sponsors looking to consolidate vendors.

Strategic Market Fit With a revenue range in the low hundreds of millions and a focus on nasal-delivery platforms, Renaissance is well-positioned to pursue partnerships with mid-to-large biotech and pharma companies accelerating intranasal therapies and specialized formulations.